Diagnosing Coronavirus SARS-COV-2

Reading time: 2 min

The diagnosis of any disease depends on the history as well as the set of symptoms and signs presented by the patient, taking into account the epidemiological situation and a lot of other data interpreted by the medical team. There is no single diagnostic test, but there are several possibilities. After that, certain complementary examinations and laboratory tests are then considered and evaluated.

When dealing with infectious diseases it is very important to have tests that quickly identify which microorganism is involved. This allows decisions to be made on the most appropriate treatment and management.

DNA

Polymerase chain reaction (PCR). SARS-CoV-2 can be identified using the PCR test carried out in a microbiology lab. This is considered the reference standard for molecular diagnosis. The test has a good level of sensitivity (i.e., the probability that a person with COVID-19 gives a positive test result; does not give false negatives), and good specificity (i.e., the probability that a person without COVID-19 has a negative test result; does not give false positives).

The test may be negative in the early stages of infection, and in these cases may provide a false sense of security. The test that detects the RNA of the virus may not reflect the presence of viable virus (with the ability to infect). At the end of the disease, the result may be that the patient is fine, they are cured, but the PCR still returns a positive result.

Aspirado nasal, detección virus

Nasal or pharyngeal smear. The PCR has limitations so the quality of the sample obtained from a nasal or pharyngeal smear is critical.

If the current number of cases increases significantly, the test would be reserved only for the highest risk patients and the most serious cases that may require hospital admission. When there is an epidemic situation, the resources must be streamlined and rationalised.

Substantiated information by:

Antoni Trilla
Eduard Vieta Pascual
Josep Maria Peri
Maica Rubinat
Mariona Violan

Published: 12 March 2020
Updated: 12 March 2020

Subscribe

Receive the latest updates related to this content.

Thank you for subscribing!

If this is the first time you subscribe you will receive a confirmation email, check your inbox

An error occurred and we were unable to send your data, please try again later.